R&I: Chemotherapy Induced Peripheral Neuropathy Market - Size, Share, Global Trends, 2014 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

R&I: Chemotherapy Induced Peripheral Neuropathy Market - Size, Share, Global Trends, 2014

Description:

GlobalData's clinical trial report, “Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H2, 2014" provides data on the Chemotherapy Induced Peripheral Neuropathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chemotherapy Induced Peripheral Neuropathy. Detailed report at: – PowerPoint PPT presentation

Number of Views:82

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: R&I: Chemotherapy Induced Peripheral Neuropathy Market - Size, Share, Global Trends, 2014


1

Chemotherapy Induced Peripheral Neuropathy Global
Clinical Trials Review, H2, 2014

No of pages 129
Publish Date October 2014
2
Description


GlobalData's clinical trial report, Chemotherapy
Induced Peripheral Neuropathy Global Clinical
Trials Review, H2, 2014" provides data on the
Chemotherapy Induced Peripheral Neuropathy
clinical trial scenario. This report provides
elemental information and data relating to the
clinical trials on Chemotherapy Induced
Peripheral Neuropathy. It includes an overview of
the trial numbers and their recruitment status as
per the site of trial conduction across the
globe. The databook offers a preliminary
coverage of disease clinical trials by their
phase, trial status, prominence of the sponsors
and also provides briefing pertaining to the
number of trials for the key drugs for treating
Chemotherapy Induced Peripheral Neuropathy. This
report is built using data and information
sourced from proprietary databases, primary and
secondary research and in-house analysis by
GlobalData's team of industry experts. Complete
report is available at http//www.reportsandint
elligence.com/chemotherapy-induced-peripheral-neur
opathy-global-clinical-trials-review-h2-2014-marke
t
3
Description

  • Scope
  • Data on the number of clinical trials conducted
    in North America, South and Central America,
    Europe, Middle-East and Africa and Asia-pacific
    and top five national contributions in each,
    along with the clinical trial scenario in BRIC
    nations
  • Clinical trial (complete and in progress) data by
    phase, trial status, subjects recruited and
    sponsor type
  • Listings of discontinued trials (suspended,
    withdrawn and terminated)Reasons to buy
  • Understand the dynamics of a particular
    indication in a condensed manner
  • Abridged view of the performance of the trials in
    terms of their status, recruitment, location,
    sponsor type and many more
  • Obtain discontinued trial listing for trials
    across the globe
  • Espy the commercial landscape of the major
    Universities / Institutes / Hospitals or
    Companies 

4
Table Of Content

  • Introduction
  • Chemotherapy Induced Peripheral Neuropathy
  • Report Guidance
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical
    Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical
    Trials in Europe
  • Get full TOC at http//www.reportsandintelligence
    .com/chemotherapy-induced-peripheral-neuropathy-gl
    obal-clinical-trials-review-h2-2014-market/table-o
    f-contents

5

FOR MORE DETAILS
Visit us at
http//www.reportsandintelligence.com/chemotherapy
-induced-peripheral-neuropathy-global-clinical-tri
als-review-h2-2014-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE Direct 1 (617) 674-4143 Toll Free
1 (855) 711-1555E-MAIL sales_at_reportsandintellig
ence.com
About PowerShow.com